U.S. markets closed

Equinix, Inc. (REIT) (EQIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
708.33+15.68 (+2.26%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close692.65
Open692.90
Bid685.00 x 800
Ask713.00 x 900
Day's Range690.70 - 712.96
52 Week Range477.87 - 839.77
Volume579,192
Avg. Volume435,658
Market Cap63.113B
Beta (5Y Monthly)0.30
PE Ratio (TTM)139.52
EPS (TTM)5.08
Earnings DateFeb 10, 2021 - Feb 15, 2021
Forward Dividend & Yield10.64 (1.54%)
Ex-Dividend DateNov 17, 2020
1y Target Est843.91
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-9% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Mizuho Initiates Coverage On Equinix With Bullish Rating

    Equinix Inc (NASDAQ: EQIX) is likely to generate strong earnings growth in 2020 and 2021, backed by favorable demand-supply trends, according to Mizuho.The Equinix Analyst: Omotayo Okusanya initiated coverage of Equinix with a Buy rating and a price target of $800.The Equinix Thesis: The Data Center REIT sector's fundamentals should remain strong in 2021, Okusanya said.He expects Equinix to continue to maintain its "superior earnings growth profile" going forward, given its high-quality portfolio and unique operating platform."We believe the laser-like focus on continuing to evolve the operating platform is also an effort by management to create further differentiation vs. peers, and adding new capabilities such as bare metal and virtual interconnection are steps in the right direction to generate higher monthly recurring revenues (MRR) per cabinet from the customer base, and to further reduce churn," the analyst wrote in a note."We believe the recent sell-off on news of successful COVID-19 vaccines is overdone and investors should buy the dip," he added.EQIX Price Action: Shares of Equinix traded around $692.53 at the time of publication.Latest Ratings for EQIX DateFirmActionFromTo Dec 2020MizuhoInitiates Coverage OnBuy Oct 2020BMO CapitalMaintainsOutperform Oct 2020Wells FargoMaintainsOverweight View More Analyst Ratings for EQIX View the Latest Analyst RatingsSee more from Benzinga * Click here for options trades from Benzinga * Evercore ISI Upgrades Square On Cash App Prospects * KeyBanc On At Home Group's Q3: 'Differentiated Growth Story'(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Benzinga

    Benzinga's Top Upgrades, Downgrades For December 3, 2020

    Upgrades * For Square Inc (NYSE: SQ), Evercore ISI Group upgraded the previous rating of In-Line to the current rating Outperform. For the third quarter, Square had an EPS of $0.34, compared to year-ago quarter EPS of $0.25. The current stock performance of Square shows a 52-week-high of 215.0 and a 52-week-low of 32.33. Moreover, at the end of the last trading period, the closing price was at $202.06. * For Waddell & Reed Financial Inc (NYSE: WDR), Evercore ISI Group upgraded the previous rating of Underperform to the current rating In-Line. Waddell & Reed Financial earned $0.48 in the third quarter, compared to $0.46 in the year-ago quarter. The current stock performance of Waddell & Reed Financial shows a 52-week-high of 18.02 and a 52-week-low of 9.8701. Moreover, at the end of the last trading period, the closing price was at $17.01. * For Tyson Foods Inc (NYSE: TSN), Piper Sandler upgraded the previous rating of Neutral to the current rating Overweight. In the fourth quarter, Tyson Foods showed an EPS of $1.81, compared to $1.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of 94.24 and a 52-week-low of 42.57. Tyson Foods closed at $66.08 at the end of the last trading period. * For Royal Dutch Shell PLC (NYSE: RDS-A), Bernstein upgraded the previous rating of Market Perform to the current rating Outperform. Royal Dutch Shell closed at $36.40 at the end of the last trading period. * JP Morgan upgraded the previous rating for Mohawk Industries Inc (NYSE: MHK) from Neutral to Overweight. In the third quarter, Mohawk Industries showed an EPS of $3.26, compared to $2.75 from the year-ago quarter. The stock has a 52-week-high of 144.37 and a 52-week-low of 56.62. At the end of the last trading period, Mohawk Industries closed at $124.72. * For Banner Corp (NASDAQ: BANR), Piper Sandler upgraded the previous rating of Neutral to the current rating Overweight. Banner earned $1.04 in the third quarter, compared to $1.16 in the year-ago quarter. The current stock performance of Banner shows a 52-week-high of 59.64 and a 52-week-low of 27.12. Moreover, at the end of the last trading period, the closing price was at $43.11. * According to Goldman Sachs, the prior rating for Tesla Inc (NASDAQ: TSLA) was changed from Neutral to Buy. For the third quarter, Tesla had an EPS of $0.76, compared to year-ago quarter EPS of $0.37. The current stock performance of Tesla shows a 52-week-high of 607.8 and a 52-week-low of 65.45. Moreover, at the end of the last trading period, the closing price was at $568.82. * KeyBanc upgraded the previous rating for Silgan Holdings Inc (NASDAQ: SLGN) from Sector Weight to Overweight. For the third quarter, Silgan Hldgs had an EPS of $1.04, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of 40.44 and a 52-week-low of 24.645. Silgan Hldgs closed at $34.01 at the end of the last trading period. Downgrades * According to MKM Partners, the prior rating for Discovery Inc (NASDAQ: DISCA) was changed from Buy to Neutral. In the third quarter, Discovery showed an EPS of $0.81, compared to $0.87 from the year-ago quarter. The current stock performance of Discovery shows a 52-week-high of 33.48 and a 52-week-low of 17.12. Moreover, at the end of the last trading period, the closing price was at $28.37. * For Stitch Fix Inc (NASDAQ: SFIX), Wells Fargo downgraded the previous rating of Equal-Weight to the current rating Underweight. Stitch Fix earned $0.44 in the fourth quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Stitch Fix shows a 52-week-high of 42.38 and a 52-week-low of 10.9. Moreover, at the end of the last trading period, the closing price was at $39.41. * BMO Capital downgraded the previous rating for Funko Inc (NASDAQ: FNKO) from Market Perform to Underperform. Funko earned $0.31 in the third quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of 17.76 and a 52-week-low of 3.12. Funko closed at $9.50 at the end of the last trading period. * According to UBS, the prior rating for XPeng Inc (NYSE: XPEV) was changed from Buy to Neutral. In the third quarter, XPeng earned $0.32. At the moment, the stock has a 52-week-high of 74.49 and a 52-week-low of 17.1101. XPeng closed at $55.90 at the end of the last trading period. * According to New Street, the prior rating for Trip.com Group Ltd (NASDAQ: TCOM) was changed from Buy to Neutral. Trip.com Group earned $0.34 in the third quarter, compared to $0.52 in the year-ago quarter. At the moment, the stock has a 52-week-high of 38.95 and a 52-week-low of 20.1. Trip.com Group closed at $33.15 at the end of the last trading period. * JP Morgan downgraded the previous rating for Stanley Black & Decker Inc (NYSE: SWK) from Overweight to Neutral. The stock has a 52-week-high of 195.0 and a 52-week-low of 70.0. At the end of the last trading period, Stanley Black & Decker closed at $178.47. * Stifel downgraded the previous rating for Splunk Inc (NASDAQ: SPLK) from Buy to Hold. In the third quarter, Splunk showed an EPS of $0.07, compared to $0.58 from the year-ago quarter. The current stock performance of Splunk shows a 52-week-high of 225.8944 and a 52-week-low of 93.92. Moreover, at the end of the last trading period, the closing price was at $205.91. * Morgan Stanley downgraded the previous rating for Pentair PLC (NYSE: PNR) from Overweight to Equal-Weight. For the third quarter, Pentair had an EPS of $0.70, compared to year-ago quarter EPS of $0.58. The stock has a 52-week-high of 58.82 and a 52-week-low of 22.01. At the end of the last trading period, Pentair closed at $51.43. * Exane BNP Paribas downgraded the previous rating for Commercial Metals Co (NYSE: CMC) from Outperform to Neutral. Commercial Metals earned $0.79 in the fourth quarter, compared to $0.76 in the year-ago quarter. The stock has a 52-week-high of 24.04 and a 52-week-low of 10.76. At the end of the last trading period, Commercial Metals closed at $20.40. * According to Independent Research, the prior rating for JPMorgan Chase & Co (NYSE: JPM) was changed from Buy to Hold. JPMorgan Chase earned $2.92 in the third quarter, compared to $2.68 in the year-ago quarter. The current stock performance of JPMorgan Chase shows a 52-week-high of 141.1 and a 52-week-low of 76.91. Moreover, at the end of the last trading period, the closing price was at $122.05. Initiations * With a current rating of Buy, National Securities initiated coverage on Trxade Group Inc (NASDAQ: MEDS). The price target seems to have been set at $15.00 for Trxade Group. Trxade Group earned $0.02 in the third quarter. The current stock performance of Trxade Group shows a 52-week-high of 11.6 and a 52-week-low of 4.01. Moreover, at the end of the last trading period, the closing price was at $4.93. * With a current rating of Outperform, RBC Capital initiated coverage on Global Blood Therapeutics Inc (NASDAQ: GBT). The price target seems to have been set at $75.00 for Global Blood Therapeutics. In the third quarter, Global Blood Therapeutics showed an EPS of $0.97, compared to $1.07 from the year-ago quarter. The stock has a 52-week-high of 87.54 and a 52-week-low of 36.49. At the end of the last trading period, Global Blood Therapeutics closed at $44.78. * With a current rating of Outperform, SMBC Nikko initiated coverage on Williams Companies Inc (NYSE: WMB). The price target seems to have been set at $26.00 for Williams Companies. For the third quarter, Williams Companies had an EPS of $0.27, compared to year-ago quarter EPS of $0.26. The current stock performance of Williams Companies shows a 52-week-high of 24.17 and a 52-week-low of 8.41. Moreover, at the end of the last trading period, the closing price was at $21.64. * With a current rating of Hold, Jefferies initiated coverage on Tattooed Chef Inc (NASDAQ: TTCF). The price target seems to have been set at $17.00 for Tattooed Chef. In the third quarter, Tattooed Chef earned $1.12. The stock has a 52-week-high of 27.2 and a 52-week-low of 14.093. At the end of the last trading period, Tattooed Chef closed at $15.42. * With a current rating of Outperform, SMBC Nikko initiated coverage on Targa Resources Corp (NYSE: TRGP). The price target seems to have been set at $30.00 for Targa Resources. In the third quarter, Targa Resources showed an EPS of $0.46, compared to $0.41 from the year-ago quarter. The stock has a 52-week-high of 42.125 and a 52-week-low of 3.66. At the end of the last trading period, Targa Resources closed at $24.16. * With a current rating of Buy, Stifel initiated coverage on Syndax Pharmaceuticals Inc (NASDAQ: SNDX). The price target seems to have been set at $32.00 for Syndax Pharmaceuticals. Syndax Pharmaceuticals earned $0.46 in the third quarter, compared to $0.41 in the year-ago quarter. The current stock performance of Syndax Pharmaceuticals shows a 52-week-high of 23.98 and a 52-week-low of 6.32. Moreover, at the end of the last trading period, the closing price was at $22.79. * With a current rating of Neutral, SMBC Nikko initiated coverage on ONEOK Inc (NYSE: OKE). The price target seems to have been set at $42.00 for ONEOK. For the third quarter, ONEOK had an EPS of $0.70, compared to year-ago quarter EPS of $0.74. At the moment, the stock has a 52-week-high of 78.48 and a 52-week-low of 12.16. ONEOK closed at $37.45 at the end of the last trading period. * With a current rating of Buy, Stifel initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN). The price target seems to have been set at $33.00 for Mersana Therapeutics. Mersana Therapeutics earned $0.33 in the third quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of 26.71 and a 52-week-low of 3.58. Mersana Therapeutics closed at $23.54 at the end of the last trading period. * With a current rating of Overweight, Cantor Fitzgerald initiated coverage on Lumos Pharma Inc (NASDAQ: LUMO). The price target seems to have been set at $32.00 for Lumos Pharma. Lumos Pharma earned $0.21 in the third quarter. The current stock performance of Lumos Pharma shows a 52-week-high of 17.4973 and a 52-week-low of 6.7436. Moreover, at the end of the last trading period, the closing price was at $15.38. * With a current rating of Buy, Stifel initiated coverage on Kura Oncology Inc (NASDAQ: KURA). The price target seems to have been set at $45.00 for Kura Oncology. For the third quarter, Kura Oncology had an EPS of $0.42, compared to year-ago quarter EPS of $0.36. At the moment, the stock has a 52-week-high of 40.62 and a 52-week-low of 6.35. Kura Oncology closed at $33.69 at the end of the last trading period. * With a current rating of Outperform, SMBC Nikko initiated coverage on Kinder Morgan Inc (NYSE: KMI). The price target seems to have been set at $18.00 for Kinder Morgan. Kinder Morgan earned $0.21 in the third quarter, compared to $0.22 in the year-ago quarter. The current stock performance of Kinder Morgan shows a 52-week-high of 22.58 and a 52-week-low of 9.42. Moreover, at the end of the last trading period, the closing price was at $14.34. * With a current rating of Buy, Mizuho initiated coverage on Equinix Inc (NASDAQ: EQIX). The price target seems to have been set at $800.00 for Equinix. Equinix earned $6.48 in the third quarter, compared to $5.52 in the year-ago quarter. The current stock performance of Equinix shows a 52-week-high of 839.77 and a 52-week-low of 477.87. Moreover, at the end of the last trading period, the closing price was at $690.62. * With a current rating of Buy, Stifel initiated coverage on Deciphera Pharmaceuticals Inc (NASDAQ: DCPH). The price target seems to have been set at $75.00 for Deciphera Pharmaceuticals. Deciphera Pharmaceuticals earned $1.13 in the third quarter, compared to $1.28 in the year-ago quarter. The current stock performance of Deciphera Pharmaceuticals shows a 52-week-high of 71.11 and a 52-week-low of 33.1. Moreover, at the end of the last trading period, the closing price was at $56.85. * Mizuho initiated coverage on CyrusOne Inc (NASDAQ: CONE) with a Neutral rating. The price target for CyrusOne is set to $74.00. In the third quarter, CyrusOne showed an EPS of $0.96, compared to $0.91 from the year-ago quarter. The stock has a 52-week-high of 86.77 and a 52-week-low of 43.72. At the end of the last trading period, CyrusOne closed at $68.51. * With a current rating of Buy, HC Wainwright & Co. initiated coverage on Yatra Online Inc (NASDAQ: YTRA). The price target seems to have been set at $3.00 for Yatra Online. Yatra Online earned $0.06 in the second quarter. At the moment, the stock has a 52-week-high of 3.82 and a 52-week-low of 0.5427. Yatra Online closed at $1.94 at the end of the last trading period. * Stifel initiated coverage on Blueprint Medicines Corp (NASDAQ: BPMC) with a Hold rating. The price target for Blueprint Medicines is set to $110.00. Blueprint Medicines earned $11.16 in the third quarter, compared to $1.93 in the year-ago quarter. The current stock performance of Blueprint Medicines shows a 52-week-high of 111.35 and a 52-week-low of 43.29. Moreover, at the end of the last trading period, the closing price was at $105.61. * With a current rating of Buy, HC Wainwright & Co. initiated coverage on Aemetis Inc (NASDAQ: AMTX). The price target seems to have been set at $10.00 for Aemetis. In the third quarter, Aemetis showed an EPS of $0.59, compared to $0.31 from the year-ago quarter. The stock has a 52-week-high of 5.1 and a 52-week-low of 0.3705. At the end of the last trading period, Aemetis closed at $2.27. * Stifel initiated coverage on ADC Therapeutics SA (NYSE: ADCT) with a Hold rating. The price target for ADC Therapeutics is set to $42.00. In the third quarter, ADC Therapeutics earned $0.58. At the moment, the stock has a 52-week-high of 56.5899 and a 52-week-low of 25.105. ADC Therapeutics closed at $37.76 at the end of the last trading period.See more from Benzinga * Click here for options trades from Benzinga * Understanding Datadog's Unusual Options Activity * Understanding American Airlines Group's Unusual Options Activity(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Equinix (EQIX) Announces Data-Center Development in Singapore
    Zacks

    Equinix (EQIX) Announces Data-Center Development in Singapore

    Given Singapore's positioning as a digital core and gateway in the Asia-Pacific region, Equinix's (EQIX) new IBX data-center development is likely to witness decent demand when completed.